speb/financial-data huggingface dataset:
MEDP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 907483000.00
MEDP income_statement (quarterly, 2025-09-30) — Amortization: 236000.00
MEDP cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 236000.00
MEDP cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 236000.00
MEDP income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 236000.00
MEDP income_statement (quarterly, 2025-09-30) — Basic Average Shares: 28136000.00
MEDP income_statement (quarterly, 2025-09-30) — Basic EPS: 3.95
MEDP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 46330000.00
MEDP cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -10713000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 119067000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 282000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 285351000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 285351000.00
MEDP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 3413000.00
MEDP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -10660000.00
MEDP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 246209000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -10725000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 45272000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -5516000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 36048000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Payable: -10725000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 34547000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 17523000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Receivables: 4861000.00
MEDP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 87463000.00
MEDP cash_flow (quarterly, 2025-09-30) — Changes In Cash: 238962000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Common Stock: 282000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 293641000.00
MEDP cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -4574000.00
MEDP income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 462964000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 285666000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Current Assets: 737285000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 834328000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 834328000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1283914000.00
MEDP cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 28510000.00
MEDP cash_flow (quarterly, 2025-09-30) — Deferred Tax: 28510000.00
MEDP cash_flow (quarterly, 2025-09-30) — Depreciation: 6813000.00
MEDP cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7049000.00
MEDP income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 7049000.00
MEDP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7049000.00
MEDP income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 7049000.00
MEDP income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 6813000.00
MEDP income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 28817000.00
MEDP income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.86
MEDP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 111135000.00
MEDP income_statement (quarterly, 2025-09-30) — EBIT: 141808000.00
MEDP income_statement (quarterly, 2025-09-30) — EBITDA: 148857000.00
MEDP cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 59000.00
MEDP cash_flow (quarterly, 2025-09-30) — End Cash Position: 285351000.00
MEDP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 3413000.00
MEDP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 235496000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -5652000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Goodwill: 662396000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 696053000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Gross PPE: 256761000.00
MEDP income_statement (quarterly, 2025-09-30) — Gross Profit: 196939000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 293641000.00
MEDP cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -10660000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 119067000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 119067000.00
MEDP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -4574000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Income: 111135000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 111135000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 111135000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 111135000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 111135000.00
MEDP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 111135000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 111135000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Interest Income: 1517000.00
MEDP income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1517000.00
MEDP cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 53000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Net PPE: 256761000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -402412000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 37189000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1899000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 37189000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1899000.00
MEDP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 148857000.00
MEDP income_statement (quarterly, 2025-09-30) — Normalized Income: 111135000.00
MEDP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 246209000.00
MEDP income_statement (quarterly, 2025-09-30) — Operating Income: 141808000.00
MEDP income_statement (quarterly, 2025-09-30) — Operating Revenue: 659903000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 28168223.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 78900000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 54317000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -5652000.00
MEDP income_statement (quarterly, 2025-09-30) — Other Income Expense: -489000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 33657000.00
MEDP cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 5729000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 25724000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 54491000.00
MEDP income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -489000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Properties: 256761000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Other Receivables: 10716000.00
MEDP income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MEDP balance_sheet (quarterly, 2025-09-30) — Payables: 26523000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 312189000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 83080000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
MEDP income_statement (quarterly, 2025-09-30) — Pretax Income: 142836000.00
MEDP cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 7987000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Receivables: 373034000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: 0.00
MEDP income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 462964000.00
MEDP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7049000.00
MEDP cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -4574000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -596237000.00
MEDP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 48082000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Share Issued: 28238296.00
MEDP cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6323000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 293641000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -402412000.00
MEDP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MEDP income_statement (quarterly, 2025-09-30) — Tax Provision: 31701000.00
MEDP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.22
MEDP balance_sheet (quarterly, 2025-09-30) — Total Assets: 1753012000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 293641000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Total Debt: 119067000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 293641000.00
MEDP income_statement (quarterly, 2025-09-30) — Total Expenses: 518095000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1459371000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1015727000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 175457000.00
MEDP income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 141808000.00
MEDP income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -1517000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 70073.00
MEDP balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 12235000.00
MEDP balance_sheet (quarterly, 2025-09-30) — Working Capital: -546629000.00
MEDP income_statement (annual, 2025-12-31) — +Operating Expense: 225683000.00
MEDP income_statement (quarterly, 2025-12-31) — +Operating Expense: 52047000.00
MEDP income_statement (annual, 2025-12-31) — +Total Revenue: 2530234000.00
MEDP income_statement (quarterly, 2025-12-31) — +Total Revenue: 708450000.00
MEDP balance_sheet (annual, 2025-12-31) — Accounts Payable: 28142000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 28142000.00
MEDP balance_sheet (annual, 2025-12-31) — Accounts Receivable: 376755000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 376755000.00
MEDP balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -123272000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -123272000.00
MEDP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 935830000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 935830000.00
MEDP income_statement (annual, 2025-12-31) — Amortization: 946000.00
MEDP income_statement (quarterly, 2025-12-31) — Amortization: 237000.00
MEDP cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 946000.00
MEDP cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 237000.00
MEDP cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 946000.00
MEDP cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 237000.00
MEDP income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 946000.00
MEDP income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 237000.00
MEDP income_statement (annual, 2025-12-31) — Basic Average Shares: 28846000.00
MEDP income_statement (quarterly, 2025-12-31) — Basic Average Shares: 28291000.00
MEDP income_statement (annual, 2025-12-31) — Basic EPS: 15.64
MEDP income_statement (quarterly, 2025-12-31) — Basic EPS: 4.78
MEDP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 669436000.00
MEDP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 285351000.00
MEDP balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 40453000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 40453000.00
MEDP cash_flow (annual, 2025-12-31) — Capital Expenditure: -31356000.00
MEDP cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4536000.00
MEDP balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 113643000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 113643000.00
MEDP balance_sheet (annual, 2025-12-31) — Capital Stock: 284000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 284000.00
MEDP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 497049000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 497049000.00
MEDP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 497049000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 497049000.00
MEDP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -860388000.00
MEDP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 22729000.00
MEDP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -31140000.00
MEDP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4473000.00
MEDP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 713223000.00
MEDP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 192652000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Account Payable: 2629000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1333000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 97083000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 39562000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -25160000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -7029000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 155042000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 28842000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Payable: 2629000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Payable: 1333000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 99712000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 40895000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -27101000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -11494000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Receivables: -106215000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Receivables: -29096000.00
MEDP cash_flow (annual, 2025-12-31) — Change In Working Capital: 96278000.00
MEDP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 22118000.00
MEDP cash_flow (annual, 2025-12-31) — Changes In Cash: -178305000.00
MEDP cash_flow (quarterly, 2025-12-31) — Changes In Cash: 210908000.00
MEDP balance_sheet (annual, 2025-12-31) — Common Stock: 284000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Common Stock: 284000.00
MEDP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 459071000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 459071000.00
MEDP cash_flow (annual, 2025-12-31) — Common Stock Payments: -917389000.00
MEDP cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
MEDP balance_sheet (annual, 2025-12-31) — Construction In Progress: 12773000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 12773000.00
MEDP income_statement (annual, 2025-12-31) — Cost Of Revenue: 1769616000.00
MEDP income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 503134000.00
MEDP balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 328243000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 328243000.00
MEDP balance_sheet (annual, 2025-12-31) — Current Assets: 989624000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Current Assets: 989624000.00
MEDP balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 854390000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 854390000.00
MEDP balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 854390000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 854390000.00
MEDP balance_sheet (annual, 2025-12-31) — Current Liabilities: 1343748000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1343748000.00
MEDP cash_flow (annual, 2025-12-31) — Deferred Income Tax: 80773000.00
MEDP cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 17407000.00
MEDP cash_flow (annual, 2025-12-31) — Deferred Tax: 80773000.00
MEDP cash_flow (quarterly, 2025-12-31) — Deferred Tax: 17407000.00
MEDP cash_flow (annual, 2025-12-31) — Depreciation: 27178000.00
MEDP cash_flow (quarterly, 2025-12-31) — Depreciation: 6894000.00
MEDP cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 28124000.00
MEDP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7131000.00
MEDP income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 28124000.00
MEDP income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 7131000.00
MEDP cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 28124000.00
MEDP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7131000.00
MEDP income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 28124000.00
MEDP income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 7131000.00
MEDP income_statement (annual, 2025-12-31) — Depreciation Income Statement: 27178000.00
MEDP income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 6894000.00
MEDP income_statement (annual, 2025-12-31) — Diluted Average Shares: 29527000.00
MEDP income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 28964000.00
MEDP income_statement (annual, 2025-12-31) — Diluted EPS: 15.28
MEDP income_statement (quarterly, 2025-12-31) — Diluted EPS: 4.67
MEDP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 451123000.00
MEDP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 135133000.00
MEDP income_statement (annual, 2025-12-31) — EBIT: 534935000.00
MEDP income_statement (quarterly, 2025-12-31) — EBIT: 153269000.00
MEDP income_statement (annual, 2025-12-31) — EBITDA: 563059000.00
MEDP income_statement (quarterly, 2025-12-31) — EBITDA: 160400000.00
MEDP cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 5918000.00
MEDP cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 790000.00
MEDP cash_flow (annual, 2025-12-31) — End Cash Position: 497049000.00
MEDP cash_flow (quarterly, 2025-12-31) — End Cash Position: 497049000.00
MEDP cash_flow (annual, 2025-12-31) — Financing Cash Flow: -860388000.00
MEDP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 22729000.00
MEDP cash_flow (annual, 2025-12-31) — Free Cash Flow: 681867000.00
MEDP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 188116000.00
MEDP income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -7731000.00
MEDP balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -4906000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -4906000.00
MEDP balance_sheet (annual, 2025-12-31) — Goodwill: 662396000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Goodwill: 662396000.00
MEDP balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 695816000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 695816000.00
MEDP balance_sheet (annual, 2025-12-31) — Gross PPE: 372142000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 372142000.00
MEDP income_statement (annual, 2025-12-31) — Gross Profit: 760618000.00
MEDP income_statement (quarterly, 2025-12-31) — Gross Profit: 205316000.00
MEDP cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 39719000.00
MEDP cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
MEDP balance_sheet (annual, 2025-12-31) — Invested Capital: 459071000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 459071000.00
MEDP cash_flow (annual, 2025-12-31) — Investing Cash Flow: -31140000.00
MEDP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4473000.00
MEDP cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
MEDP balance_sheet (annual, 2025-12-31) — Land And Improvements: 5140000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 5140000.00
MEDP balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 113643000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 113643000.00
MEDP balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 113643000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 113643000.00
MEDP balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 142609000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 142609000.00
MEDP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -917389000.00
MEDP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
MEDP income_statement (annual, 2025-12-31) — Net Income: 451123000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Income: 135133000.00
MEDP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 451123000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 135133000.00
MEDP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 451123000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 135133000.00
MEDP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 451123000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 135133000.00
MEDP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 451123000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 135133000.00
MEDP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 451123000.00
MEDP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 135133000.00
MEDP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 451123000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 135133000.00
MEDP income_statement (annual, 2025-12-31) — Net Interest Income: 12780000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Interest Income: 3722000.00
MEDP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
MEDP income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 12780000.00
MEDP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 3722000.00
MEDP cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 216000.00
MEDP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 63000.00
MEDP balance_sheet (annual, 2025-12-31) — Net PPE: 248870000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Net PPE: 248870000.00
MEDP cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -31356000.00
MEDP cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -4536000.00
MEDP cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
MEDP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -236745000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -236745000.00
MEDP balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 19223000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 19223000.00
MEDP balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1355000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1355000.00
MEDP balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 19223000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 19223000.00
MEDP balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1355000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1355000.00
MEDP income_statement (annual, 2025-12-31) — Normalized EBITDA: 570790000.00
MEDP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 160400000.00
MEDP income_statement (annual, 2025-12-31) — Normalized Income: 457555192.00
MEDP income_statement (quarterly, 2025-12-31) — Normalized Income: 135133000.00
MEDP cash_flow (annual, 2025-12-31) — Operating Cash Flow: 713223000.00
MEDP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 192652000.00
MEDP income_statement (annual, 2025-12-31) — Operating Income: 534935000.00
MEDP income_statement (quarterly, 2025-12-31) — Operating Income: 153269000.00
MEDP income_statement (annual, 2025-12-31) — Operating Revenue: 2530234000.00
MEDP income_statement (quarterly, 2025-12-31) — Operating Revenue: 708450000.00
MEDP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 28370780.00
MEDP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 28370780.00
MEDP balance_sheet (annual, 2025-12-31) — Other Current Assets: 90497000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 90497000.00
MEDP balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 52834000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 52834000.00
MEDP balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -4906000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -4906000.00
MEDP income_statement (annual, 2025-12-31) — Other Income Expense: -5338000.00
MEDP income_statement (quarterly, 2025-12-31) — Other Income Expense: -158000.00
MEDP balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 33420000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 33420000.00
MEDP cash_flow (annual, 2025-12-31) — Other Non Cash Items: 22139000.00
MEDP cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 5243000.00
MEDP balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 21939000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 21939000.00
MEDP balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 57655000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 57655000.00
MEDP income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 2393000.00
MEDP income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 7573000.00
MEDP balance_sheet (annual, 2025-12-31) — Other Properties: 171167000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Properties: 171167000.00
MEDP balance_sheet (annual, 2025-12-31) — Other Receivables: 25352000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Other Receivables: 25352000.00
MEDP income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDP income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDP balance_sheet (annual, 2025-12-31) — Payables: 28142000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Payables: 28142000.00
MEDP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 356385000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 356385000.00
MEDP balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 80139000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 80139000.00
MEDP balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
MEDP balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
MEDP income_statement (annual, 2025-12-31) — Pretax Income: 542377000.00
MEDP income_statement (quarterly, 2025-12-31) — Pretax Income: 156833000.00
MEDP cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 57001000.00
MEDP cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 22729000.00
MEDP balance_sheet (annual, 2025-12-31) — Properties: 0.00
MEDP balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MEDP cash_flow (annual, 2025-12-31) — Purchase Of PPE: -31356000.00
MEDP cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -4536000.00
MEDP balance_sheet (annual, 2025-12-31) — Receivables: 402078000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Receivables: 402078000.00
MEDP balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -29000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -29000.00
MEDP income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1769616000.00
MEDP income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 503134000.00
MEDP income_statement (annual, 2025-12-31) — Reconciled Depreciation: 28124000.00
MEDP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7131000.00
MEDP cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
MEDP cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -917389000.00
MEDP cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
MEDP balance_sheet (annual, 2025-12-31) — Retained Earnings: -459981000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -459981000.00
MEDP income_statement (annual, 2025-12-31) — Selling General And Administration: 197559000.00
MEDP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 44916000.00
MEDP balance_sheet (annual, 2025-12-31) — Share Issued: 28440403.00
MEDP balance_sheet (quarterly, 2025-12-31) — Share Issued: 28440403.00
MEDP cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
MEDP cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
MEDP cash_flow (annual, 2025-12-31) — Stock Based Compensation: 34786000.00
MEDP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 5620000.00
MEDP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 459071000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 459071000.00
MEDP balance_sheet (annual, 2025-12-31) — Tangible Book Value: -236745000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -236745000.00
MEDP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1298808.00
MEDP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MEDP income_statement (annual, 2025-12-31) — Tax Provision: 91254000.00
MEDP income_statement (quarterly, 2025-12-31) — Tax Provision: 21700000.00
MEDP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.17
MEDP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.14
MEDP balance_sheet (annual, 2025-12-31) — Total Assets: 1975472000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Total Assets: 1975472000.00
MEDP balance_sheet (annual, 2025-12-31) — Total Capitalization: 459071000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 459071000.00
MEDP balance_sheet (annual, 2025-12-31) — Total Debt: 113643000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Total Debt: 113643000.00
MEDP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 459071000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 459071000.00
MEDP income_statement (annual, 2025-12-31) — Total Expenses: 1995299000.00
MEDP income_statement (quarterly, 2025-12-31) — Total Expenses: 555181000.00
MEDP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1516401000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1516401000.00
MEDP balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 985848000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 985848000.00
MEDP balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 172653000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 172653000.00
MEDP income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 534935000.00
MEDP income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 153269000.00
MEDP income_statement (annual, 2025-12-31) — Total Other Finance Cost: -12780000.00
MEDP income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -3722000.00
MEDP income_statement (annual, 2025-12-31) — Total Unusual Items: -7731000.00
MEDP income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -7731000.00
MEDP balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 69623.00
MEDP balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 69623.00
MEDP balance_sheet (annual, 2025-12-31) — Treasury Stock: 12156000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 12156000.00
MEDP balance_sheet (annual, 2025-12-31) — Working Capital: -354124000.00
MEDP balance_sheet (quarterly, 2025-12-31) — Working Capital: -354124000.00
MEDP income_statement (quarterly, 2026-03-31) — +Operating Expense: 54823000.00
MEDP income_statement (quarterly, 2026-03-31) — +Total Revenue: 706604000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 34429000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 370407000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 953416000.00
MEDP income_statement (quarterly, 2026-03-31) — Amortization: 155000.00
MEDP cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 155000.00
MEDP cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 155000.00
MEDP income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 155000.00
MEDP income_statement (quarterly, 2026-03-31) — Basic Average Shares: 28445000.00
MEDP income_statement (quarterly, 2026-03-31) — Basic EPS: 4.35
MEDP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 497049000.00
MEDP cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6814000.00
MEDP cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -6814000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 122256000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 286000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 652681000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 652681000.00
MEDP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 12670000.00
MEDP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -6748000.00
MEDP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 151788000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 84000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1300000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -5294000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -8215000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Payable: 84000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1216000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1795000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Receivables: 7822000.00
MEDP cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -8698000.00
MEDP cash_flow (quarterly, 2026-03-31) — Changes In Cash: 157710000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Common Stock: 286000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 598314000.00
MEDP cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
MEDP income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 510278000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 344462000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Current Assets: 1139055000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 856344000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 856344000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1345014000.00
MEDP cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 18543000.00
MEDP cash_flow (quarterly, 2026-03-31) — Deferred Tax: 18543000.00
MEDP cash_flow (quarterly, 2026-03-31) — Depreciation: 6751000.00
MEDP cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 6906000.00
MEDP income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 6906000.00
MEDP cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6906000.00
MEDP income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 6906000.00
MEDP income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 6751000.00
MEDP income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 28962000.00
MEDP income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.28
MEDP income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 123870000.00
MEDP income_statement (quarterly, 2026-03-31) — EBIT: 141503000.00
MEDP income_statement (quarterly, 2026-03-31) — EBITDA: 148409000.00
MEDP cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2078000.00
MEDP cash_flow (quarterly, 2026-03-31) — End Cash Position: 652681000.00
MEDP cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 12670000.00
MEDP cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 144974000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -7121000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Goodwill: 662396000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 695661000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Gross PPE: 263360000.00
MEDP income_statement (quarterly, 2026-03-31) — Gross Profit: 196326000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Invested Capital: 598314000.00
MEDP cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -6748000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 122256000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 122256000.00
MEDP cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
MEDP income_statement (quarterly, 2026-03-31) — Net Income: 123870000.00
MEDP income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 123870000.00
MEDP income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 123870000.00
MEDP income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 123870000.00
MEDP income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 123870000.00
MEDP cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 123870000.00
MEDP income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 123870000.00
MEDP income_statement (quarterly, 2026-03-31) — Net Interest Income: 5117000.00
MEDP income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 5117000.00
MEDP cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 66000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Net PPE: 263360000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -97347000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 3220000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3925000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 3220000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3925000.00
MEDP income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 148409000.00
MEDP income_statement (quarterly, 2026-03-31) — Normalized Income: 123870000.00
MEDP cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 151788000.00
MEDP income_statement (quarterly, 2026-03-31) — Operating Income: 141503000.00
MEDP income_statement (quarterly, 2026-03-31) — Operating Revenue: 706604000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 28559689.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 91793000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 48182000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -7121000.00
MEDP income_statement (quarterly, 2026-03-31) — Other Income Expense: 971000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 33265000.00
MEDP cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6249000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 28317000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 60104000.00
MEDP income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 971000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Properties: 263360000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Other Receivables: 24202000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Payables: 34429000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 378891000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 61597000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
MEDP income_statement (quarterly, 2026-03-31) — Pretax Income: 147591000.00
MEDP cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 12670000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Receivables: 394581000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -28000.00
MEDP income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 510278000.00
MEDP income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6906000.00
MEDP cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
MEDP balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -336111000.00
MEDP income_statement (quarterly, 2026-03-31) — Selling General And Administration: 47917000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Share Issued: 28629312.00
MEDP cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4918000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 598314000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -97347000.00
MEDP income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDP income_statement (quarterly, 2026-03-31) — Tax Provision: 23721000.00
MEDP income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.16
MEDP balance_sheet (quarterly, 2026-03-31) — Total Assets: 2129613000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 598314000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Total Debt: 122256000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 598314000.00
MEDP income_statement (quarterly, 2026-03-31) — Total Expenses: 565101000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1531299000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 990558000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 186285000.00
MEDP income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 141503000.00
MEDP income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -5117000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 69623.00
MEDP balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 12156000.00
MEDP balance_sheet (quarterly, 2026-03-31) — Working Capital: -205959000.00
MEDP income_statement (quarterly, 2026-06-30) — +Operating Expense: 54813000.00
MEDP income_statement (quarterly, 2026-06-30) — +Total Revenue: 707331000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Accounts Payable: 37527000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Accounts Receivable: 420560000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Additional Paid In Capital: 964183000.00
MEDP income_statement (quarterly, 2026-06-30) — Amortization: 155000.00
MEDP cash_flow (quarterly, 2026-06-30) — Amortization Cash Flow: 155000.00
MEDP cash_flow (quarterly, 2026-06-30) — Amortization Of Intangibles: 155000.00
MEDP income_statement (quarterly, 2026-06-30) — Amortization Of Intangibles Income Statement: 155000.00
MEDP income_statement (quarterly, 2026-06-30) — Basic Average Shares: 28174000.00
MEDP income_statement (quarterly, 2026-06-30) — Basic EPS: 4.31
MEDP cash_flow (quarterly, 2026-06-30) — Beginning Cash Position: 652681000.00
MEDP cash_flow (quarterly, 2026-06-30) — Capital Expenditure: -23911000.00
MEDP cash_flow (quarterly, 2026-06-30) — Capital Expenditure Reported: -23911000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Capital Lease Obligations: 120100000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Capital Stock: 279000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Cash And Cash Equivalents: 502688000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Cash Cash Equivalents And Short Term Investments: 502688000.00
MEDP cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Financing Activities: -288340000.00
MEDP cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Investing Activities: -23885000.00
MEDP cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Operating Activities: 162011000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Account Payable: -129000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Accrued Expense: 45017000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Other Current Liabilities: -7063000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Other Working Capital: 42914000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Payable: -129000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Payables And Accrued Expense: 44888000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Prepaid Assets: -14154000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Receivables: -47183000.00
MEDP cash_flow (quarterly, 2026-06-30) — Change In Working Capital: 19402000.00
MEDP cash_flow (quarterly, 2026-06-30) — Changes In Cash: -150214000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Common Stock: 279000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Common Stock Equity: 433861000.00
MEDP cash_flow (quarterly, 2026-06-30) — Common Stock Payments: -294764000.00
MEDP income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 505694000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Current Accrued Expenses: 371648000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Current Assets: 1050285000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Current Deferred Liabilities: 904722000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Current Deferred Revenue: 904722000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Current Liabilities: 1435429000.00
MEDP cash_flow (quarterly, 2026-06-30) — Deferred Income Tax: 4281000.00